Hangzhou Tigermed Consulting Co., Ltd (300347.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 48.41B |
| Enterprise Value | 48.1B |
| P/E Ratio | 56.17 |
| PEG Ratio | 0.42 |
| Price/Sales Ratio | 5.22 |
| Price/Book Ratio | 1.95 |
| Enterprise/Revenue | 5.16 |
| Enterprise/EBITDA | 22.79 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 6.83B |
| Revenue/Share | 8.65 |
| Gross Profit | 1.87B |
| EBITDA | 820.3M |
| Net Income | 887.89M |
| Diluted EPS | 1.04 |
Balance Sheet
| Total Cash | 2.2B |
| Total Cash/Share | 2.69 |
| Total Debt | 1.73B |
| Total Debt/Equity | 0.08 |
| Current Ratio | 2.3 |
| Book Value Per Share | 30.05 |
Price History
| 52-Week Change | -24.46 |
| 52-Week High | 71.18 |
| 52-Week Low | 35.57 |
| Moving Average 50 Days | 44.24 |
| Moving Average 200 Days | 52.96 |
Statistics
| Average Volume | 22.11M |
| Shares Outstanding | 737.9M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.13 |
| Trailing Annual Dividend Yield | 0.25 |
| Payout Ratio | 0.43 |
| Last Split Factor | 3:2 |
| Last Split Date | July 01, 2019 |
AD
